Malaysian Genomics Resource Centre

Equities

MGRC

MYQ0155OO000

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
0.4 MYR -1.23% Intraday chart for Malaysian Genomics Resource Centre -4.76% -10.11%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Malaysian Genomics Resource Centre Berhad Announces Aswath A/L Ramakrishnan, Independent and Non Executive Director Was Not Reelected by Shareholders At the Annual General Meeting CI
Malaysian Genomics Resource, DE Cell Forge Strategic Alliance MT
Malaysian Genomics Resource, Universiti Sains Malaysia Tie Up for Genetics Study MT
Malaysian Genomics Resource Centre Berhad Announces Collaboration Agreement with Universiti Sains Malaysia CI
Malaysian Genomics Resource Centre Berhad Announces Redesignation of Encik Muhammad Badri Bin Hussin to Chief Operating Officer from Director CI
Malaysian Genomics Resource Centre Berhad Announces Appointment of Mohammad Hasni Bin Ibrahim as Independent and Non Executive Member of Audit Committee CI
Malaysian Genomics Resource Centre Berhad Announces Resignation of Muhammad Badri Bin Hussin as Independent and Non Executive Member of Audit Committee CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Eighteen Months Ended December 31, 2023 CI
Malaysian Genomics Resource Centre Berhad Appoints Mohammad Hasni Bin Ibrahim as Independent and Non Executive Director CI
Malaysian Genomics Resource Centre Berhad Appoints Datuk Wira Muhammad Faizal Bin Zainol as Independent and Non Executive Director CI
Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Aswath A/L Ramakrishnan as A Non-Audit and Risk Management Committee Member CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Third Quarter Ended September 30, 2023 CI
Malaysian Genomics to Deploy AntChain Blockchain Technology MT
Malaysian Genomics Unit, Dynamic Prestige Consultancy to Operate Dialysis Centers MT
Genotec Sdn Bhd announced that it expects to receive funding from Malaysian Genomics Resource Centre Berhad CI
Malaysian Genomics Resource Centre Changes Financial Year End to December 31 MT
Malaysian Genomics Resource Centre Berhad Announces Change in Financial Year End from 30 June to 31 December CI
Malaysian Genomics Resource Centre Berhad Appoints Encik Muhammad Badri Bin Hussin, Age 50, as Member of Audit Committee, Date of Change 25 Oct 2023 CI
Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Muhammad Badri Bin Hussin as Independent and Non Executive Director CI
Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Mohamad Ruzaini Bin Hamzah as Independent and Non Executive Director CI
Malaysian Genomics Resource Centre Berhad Announces Resignation of Encik Sasha Omar Firdaus Bin Aamir Nordin as Chief Executive Officer CI
Malaysian Genomics, Persatuan Pentas Anak Tie Up for Product, Services Promotion MT
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023 CI
Malaysian Genomics Resource Centre Berhad Announces Resignation of Aswath A/L Ramakrishnan as Independent and Non Executive Member of Nomination and Remuneration Committee CI
Chart Malaysian Genomics Resource Centre
More charts
Malaysian Genomics Resource Centre Berhad is a Malaysia-based company, which is engaged in providing personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. Its services include Genome Sequencing Services, Genome Analysis Services, Genetic Screening Services and Cancer Immunotherapy. Its whole genome sequencing (WGS) is carried out to obtain the sequence of the entire genome from any eukaryotic or prokaryotic organism. This includes plant, animal, microbial, and human genomes. It offers both de novo sequencing and resequencing as part of its WGS service. Its Genome analysis includes services, such as bioinformatics, trait analysis, and trio sequencing. Its Genetic screening includes Dtect, which offers a range of test panels designed to screen for genetic markers in an individual’s deoxyribonucleic acid (DNA). Its Cancer Immunotherapy includes chimeric antigen receptor (CAR) T-Cell immunotherapy.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MGRC Stock
  4. News Malaysian Genomics Resource Centre
  5. Malaysian Genomics Resource, Universiti Sains Malaysia Tie Up for Genetics Study